Skip to main content

Table 3 Comparison of baseline characteristics and parameters between participants and those who withdrew from the study

From: Effects of toner-handling work on respiratory function, chest X-ray findings, and biomarkers of inflammation, allergy, and oxidative stress: a 10-year prospective Japanese cohort study

Parameters (unit)

Toner-handling group

Non-toner-handling group

Participants

Withdrawal

P-value

Participants

Withdrawal

P-value

n = 684

n = 203

n = 414

n = 167

M (SD)/%

M (SD)/%

M (SD)/%

M (SD)/%

Age (years)

38.0

(6.9)

41.2

(7.2)

< 0.001

38.6

(6.1)

38.3

(7.4)

0.629

BMI (kg/m2)

23.3

(2.9)

23.5

(3.0)

0.434

23.7

(3.0)

23.6

(2.9)

0.786

Current smoker

52.0%

48.3%

0.379

44.4%

52.7%

0.081

Prevalence of respiratory diseases (%)

 Asthma

9.9%

7.9%

0.416

9.7%

12.0%

0.451

 Allergic rhinitis

51.2%

50.7%

0.936

48.6%

47.3%

0.854

 Allergic dermatitis

21.6%

18.2%

0.326

22.9%

20.4%

0.581

 Pneumonia

0.6%

0.0%

0.579

0.5%

0.0%

1.000

 Sinusitis

2.5%

3.4%

0.462

1.4%

3.0%

0.310

Ratio of workers handling harmful substances (%)

 Workers handling dust other than toner

3.8%

0.0%

0.002

0.2%

0.6%

0.493

 Workers handling organic solvent

25.6%

28.6%

0.414

2.9%

3.0%

1.000

Respiratory function tests

 VC (l)

4.2

(0.6)

4.1

(0.6)

< 0.001

4.2

(0.6)

4.2

(0.6)

0.606

 %VC (%)

92.9

(107.0)

90.7

(10.5)

0.012

91.8

(9.8)

91.9

(9.9)

0.895

 FEV1 (l)

3.5

(0.5)

3.4

(0.5)

< 0.001

3.5

(0.5)

3.5

(0.5)

0.759

 %FEV1 (%)

95.3

(11.3)

93.9

(10.7)

0.120

94.6

(10.8)

94.2

(10.9)

0.700

 FEV1/FVC (%)

83.1

(6.1)

82.8

(5.5)

0.552

83.0

(6.0)

82.7

(6.0)

0.596

 %FEV1/FVC (%)

100.0

(6.9)

100.5

(6.9)

0.344

100.3

(7.2)

99.7

(7.0)

0.410

 V25 (l/s)

1.6

(0.5)

1.5

(0.4)

0.002

1.6

(0.5)

1.6

(0.6)

0.669

 %V25 (%)

68.5

(20.2)

67.4

(18.9)

0.500

67.3

(18.3)

67.4

(19.9)

0.974

Biomarkers

 CRP (mg/dl)

0.08

(0.16)

0.11

(0.24)

0.135

0.10

(0.19)

0.10

(0.24)

0.935

 IgE (IU/ml)

194.1

(386.2)

229.0

(360.2)

0.313

206.4

(436.5)

252.7

(429.4)

0.251

 IL-4 (pg/ml)

19.9

(31.7)

16.6

(18.3)

0.219

10.8

(35.8)

10.7

(14.4)

0.988

 IL-6 (pg/ml)

1.3

(3.2)

1.4

(3.0)

0.763

1.3

(5.5)

0.9

(0.8)

0.430

 IL-8 (pg/ml)

3.2

(22.0)

1.8

(9.2)

0.449

1.1

(0.7)

1.2

(1.0)

0.365

 IFN-γ (IU/ml)

0.1

(0.1)

0.1

(0.1)

0.902

0.1

(0.1)

0.1

(0.1)

0.220

 8- OHdG/Creatinine (ng/mg)

3.9

(1.4)

3.9

(1.9)

0.883

3.8

(1.5)

3.8

(1.4)

0.692

  1. M mean, SD standard deviation, BMI body mass index, VC vital capacity, %VC percentage of VC to predicted VC value, FEV1 forced expiratory volume in 1 s, %FEV1 percentage of FEV1 to predicted FEV1 value, FEV1/FVC percentage of forced expiratory volume in 1 s, %FEV1/FVC percentage of FEV1/FVC to predicted FEV1/FVC value, V25 maximal expiratory flow at 25% forced VC, CRP C-reactive protein, IgE immunoglobulin E, IL interleukin, IFN-γ interferon-gamma, 8-OHdG 8-hydroxy-2′-deoxyguanosine